CHRISTOPHER HANSEN: Open Payments
NPI 1780934885 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,986 in 152 payments from 20 companies in 2025. Trend: 2023 $2,130 · 2024 $2,850 · 2025 $2,986
Food & beverage: $2,986
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $569 |
| Neurocrine BioSciences, Inc. | 20 | $357 |
| Indivior Inc. | 8 | $353 |
| Vanda Pharmaceuticals Inc. | 10 | $228 |
| Lundbeck LLC | 10 | $176 |
| Teva Pharmaceuticals USA, Inc. | 12 | $173 |
| Otsuka America Pharmaceutical, Inc. | 9 | $164 |
| E.R. Squibb & Sons, L.L.C. | 8 | $162 |
| Alkermes, Inc. | 8 | $155 |
| Axsome Therapeutics, Inc. | 8 | $146 |
Products named: VRAYLAR, INGREZZA, SUBLOCADE, REXULTI, FANAPT, COBENFY, AUSTEDO XR, Auvelity.
Industry payments across AZ — which companies pay providers there.
